Business Segment Information (Tables)

12 Months Ended

Dec. 31, 2011

Business Segments

Schedule of Segment Reporting Information, by Segment [Table Text Block]

(In millions)			2011		2010		2009
Revenues
	Analytical Technologies		$	3,845.4	$	3,238.2	$	2,918.8
	Specialty Diagnostics			2,469.9		2,149.0		2,150.4
	Laboratory Products and Services			5,762.9		5,473.0		5,073.7
	Eliminations			(519.4)		(467.1)		(401.9)
		Consolidated revenues		11,558.8		10,393.1		9,741.0
Segment Income
	Analytical Technologies (a)			720.0		550.1		456.9
	Specialty Diagnostics (a)			598.4		487.9		457.7
	Laboratory Products and Services (a)			810.9		781.2		708.7
		Subtotal reportable segments (a)		2,129.3		1,819.2		1,623.3
	Cost of revenues charges			(72.6)		(13.2)		(6.7)
	Selling, general and administrative charges, net			(61.5)		(3.0)		(1.5)
	Restructuring and other costs, net			(96.5)		(60.2)		(58.9)
	Amortization of acquisition-related intangible assets			(647.9)		(554.7)		(579.9)
		Consolidated operating income		1,250.8		1,188.1		976.3
	Other expense, net (b)			(118.0)		(100.4)		(122.5)
	Income from continuing operations before provision for income taxes		$	1,132.8	$	1,087.7	$	853.8
Depreciation
	Analytical Technologies		$	61.0	$	54.6	$	54.2
	Specialty Diagnostics			50.1		37.3		33.5
	Laboratory Products and Services			100.6		93.1		91.7
		Consolidated depreciation	$	211.7	$	185.0	$	179.4
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

(In millions)			2011		2010		2009
Total Assets
	Analytical Technologies		$	6,262.8	$	4,266.4	$	3,731.5
	Specialty Diagnostics			8,319.6		4,575.9		4,827.3
	Laboratory Products and Services			10,713.9		10,768.1		10,797.1
	Corporate/Other (c)			1,537.4		1,739.0		2,269.1
		Consolidated total assets	$	26,833.7	$	21,349.4	$	21,625.0
Capital Expenditures
	Analytical Technologies		$	71.3	$	45.6	$	36.6
	Specialty Diagnostics			63.2		51.0		47.2
	Laboratory Products and Services			113.9		123.4		81.7
	Corporate/Other			12.5		25.4		32.0
		Consolidated capital expenditures	$	260.9	$	245.4	$	197.5
(c)	Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices and assets of the discontinued operations.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

(In millions)			2011		2010		2009
Revenues
	Analytical Technologies		$	3,845.4	$	3,238.2	$	2,918.8
	Specialty Diagnostics			2,469.9		2,149.0		2,150.4
	Laboratory Products and Services			5,762.9		5,473.0		5,073.7
	Eliminations			(519.4)		(467.1)		(401.9)
		Consolidated revenues		11,558.8		10,393.1		9,741.0
Segment Income
	Analytical Technologies (a)			720.0		550.1		456.9
	Specialty Diagnostics (a)			598.4		487.9		457.7
	Laboratory Products and Services (a)			810.9		781.2		708.7
		Subtotal reportable segments (a)		2,129.3		1,819.2		1,623.3
	Cost of revenues charges			(72.6)		(13.2)		(6.7)
	Selling, general and administrative charges, net			(61.5)		(3.0)		(1.5)
	Restructuring and other costs, net			(96.5)		(60.2)		(58.9)
	Amortization of acquisition-related intangible assets			(647.9)		(554.7)		(579.9)
		Consolidated operating income		1,250.8		1,188.1		976.3
	Other expense, net (b)			(118.0)		(100.4)		(122.5)
	Income from continuing operations before provision for income taxes		$	1,132.8	$	1,087.7	$	853.8
Depreciation
	Analytical Technologies		$	61.0	$	54.6	$	54.2
	Specialty Diagnostics			50.1		37.3		33.5
	Laboratory Products and Services			100.6		93.1		91.7
		Consolidated depreciation	$	211.7	$	185.0	$	179.4
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

(In millions)		2011		2010		2009
Revenues (d)
	United States	$	6,023.9	$	5,806.8	$	5,528.5
	Germany		698.3		592.9		541.3
	China		559.6		405.3		352.7
	United Kingdom		472.3		409.6		418.6
	Other		3,804.7		3,178.5		2,899.9
		$	11,558.8	$	10,393.1	$	9,741.0
Long-lived Assets (e)
	United States	$	797.9	$	708.5	$	673.6
	Germany		158.6		121.7		127.9
	United Kingdom		209.2		170.4		158.2
	Other		445.6		319.3		292.8
		$	1,611.3	$	1,319.9	$	1,252.5
(d)	Revenues are attributed to countries based on customer location.
(e)	Includes property, plant and equipment, net.